Navigation Links
New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease
Date:11/8/2007

First-of-its-kind procedure from Colorado-based company

DENVER, Nov. 8 /PRNewswire/ -- Regenerative Sciences, Inc., has launched its patent-pending Regenexx(TM) procedure, which uses a patient's own stem cells to regenerate bone and cartilage -- a welcome relief for the more than 20 million Americans who suffer from painful and debilitating orthopedic conditions.

"The Regenexx procedure is different from all other treatments available today," said Chris Centeno, M.D., creator of Regenexx and an international expert and specialist in musculoskeletal, spinal and neurological injury. "Prior to Regenexx, physicians were limited in what they could offer degenerative joint patients: surgery or life with pain. Now physicians have a new tool in their tool kit."

In sanctioned clinical trials, Regenexx has been demonstrated to be safe and regenerates normal healthy tissues. A patient's stem cells are extracted with a needle from the hip, grown in culture at a Rengerative Sciences lab and then re-implanted into the patient at a doctor's office with a "needle out, needle in" approach, which substantially reduces downtime for the patient.

Unlike joint replacement or micro fracture that require weeks or months of being on crutches and pain medicines, the Regenexx procedure has no downtime. Most patients return to normal activity within 24 hours of completing the procedure.

A published clinical trial was conducted with a 46-year-old woman who had a two-year history of knee pain that began after being kicked in the shin during a martial arts class. Bone marrow was drawn from the patient, and in the next nine days, the marrow was used to grow mesenchymal stem cells, which have the ability to grow into bone, cartilage and muscle tissues. The grown stem cells initially taken from the patient were injected into her knee once a week for the next three weeks. Three months after the procedure, the patient reported that her pain had essentially d
'/>"/>

SOURCE Regenerative Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
2. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
3. UK junior doctors gaining less experience of common procedures
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Eligard(R) six-month formulation successfully completes European approval procedure
6. Smoking can harm the long-term effects of some oral surgery procedures
7. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
8. Study Shows Cosmetic Surgery on the Rise as Safety and Efficacy of Procedures Increase
9. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
10. Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year
11. Decrease in the use of radiotherapy procedures for the treatment of cancer in hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... YORK, Dec. 14 Josie Raper, a 29 year-old ... in six months with the help of the Dr. Siegal,s ... on the Joy Fit Club segment on NBC,s Today Show. ... Joy Bauer, airs twice a month and salutes those who ... in 2007 and has kept it off for two years. ...
(Date:12/14/2009)... Athens, Ga. A new study published by researchers ... Center in Tampa, Fla., has found that cancer patients ... patients with cancer alone, even after controlling for factors ... But the study, published in the early online edition ... also argues that a diagnosis of dementia shouldn,t discourage ...
(Date:12/14/2009)... of medication-related problems, including under treatment, suboptimal drugs, suboptimal ... their quality of life. Now new research (1), from ... of North Carolina at Chapel Hill shows that blacks ... medical regimens is a particular issue for this group. ... disparities in the quality of medication use appears this ...
(Date:12/14/2009)... clothing supplier, MPE, offers protective garments online to military and ... ... Hammond, Ind. (PRWEB) December 14, 2009 -- Miller,s Precision ... garments , announces its recent approval as a vendor on ... approved DOD EMALL vendor, MPE can provide military, government and ...
(Date:12/14/2009)... Racial disparities seen for ,standard-of-care, breast cancer treatment, study ... new study finds a significant racial disparity in breast ... white counterparts to receive radiation therapy after a lumpectomy. ... care for the treatment of breast cancer that is ... published in the Dec. 14 issue of the journal ...
Breaking Medicine News(10 mins):Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 2Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 3Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 4Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 2Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 3Health News:Racial differences in medication use 2Health News:MPE Inc., a Leading Supplier of Recycled Protective Garments, Becomes Approved Vendor on DOD EMALL 2Health News:After Lumpectomy, Radiation Rates Lower for Black Women 2
... Disease Patients Rising, CHICAGO, April 2 ... disease and, according to the latest research,from Prevent ... number,is continuing to climb. With more than 130 ... million suffer from leading causes of vision loss ...
... Ready for Action on the House Floor, WASHINGTON, ... Bernadette A. Toomey, President and CEO, American Lung,Association:, ... Energy and Commerce Committee for its passage of the ... urge the full,House to quickly take action to move ...
... more, it predicts major episodes, study finds , , WEDNESDAY, ... in young adults can increase their risk of developing ... of almost 600 young adults found that those with ... sleeplessness gradually increased over two decades, especially among women. ...
... would welcome an advance promising to dramatically reduce their ... at Washington University School of Medicine in St. Louis ... The researchers focused a powerful drug directly on tumors ... drug dose 1,000 times lower than used previously for ...
... Sebring Convertible Winner To Be Part Of Live Auction At ADA,s ... Annual Gala At Ritz-Carlton Dearborn, Donation By Chrysler Jeep Superstores Will Help Children ... ... Diabetes research,advocacy and education received a big boost thanks to the generous ...
... are running for president or looking for a clerical ... are a woman, Yale University psychologist Victoria Brescoll has ... recently completed three separate studies to explore a phenomenon ... Senator Hillary Clinton: People accept and even reward men ...
Other Medicine News:Health News:Eye Disease Continuing to Increase Among Americans 2Health News:Eye Disease Continuing to Increase Among Americans 3Health News:Persistent Insomnia Leads to Depression in Young Adults 2Health News:Nano-sized technology has super-sized effect on tumors 2Health News:Nano-sized technology has super-sized effect on tumors 3Health News:Diabetes Research, Advocacy and Education Gets Big Boost with Donation of Two- Year Lease for 2008 Chrysler Sebring Convertible 2Health News:Studies' message to women: Keep your cool 2
(Date:12/14/2009)... 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. ... had received a complete response letter from the ... its New Drug Application ("NDA") for Onrigin(TM) (laromustine) ... indicates that the FDA cannot approve the Company,s ... to address remaining issues. ,, Alan Kessman, Chief ...
(Date:12/14/2009)... Cancer patients in Finland have gained access to ... radiotherapy technology from Varian Medical Systems (NYSE: ... clinic in the Nordic region. Clinicians at Docrates ... precise form of radiotherapy to treat patients with ... and prostate. ,, RapidArc, which enables clinicians to ...
(Date:12/14/2009)... 14 According to Millennium Research Group ... intelligence, increased use of safety devices for small-bore ... a key driver of the enteral feeding device ... new US and European Markets for Enteral ... giving set segment will experience the greatest impact ...
Breaking Medicine Technology:Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Sanofi aventis Announces Second Quarter 2009 Results 13244 1Sanofi aventis Announces Second Quarter 2009 Results 13244 2Sanofi aventis Announces Second Quarter 2009 Results 13244 3Sanofi aventis Announces Second Quarter 2009 Results 13244 4Sanofi aventis Announces Second Quarter 2009 Results 13244 5Sanofi aventis Announces Second Quarter 2009 Results 13244 6Sanofi aventis Announces Second Quarter 2009 Results 13244 7Sanofi aventis Announces Second Quarter 2009 Results 13244 8Sanofi aventis Announces Second Quarter 2009 Results 13244 9Sanofi aventis Announces Second Quarter 2009 Results 13244 10Sanofi aventis Announces Second Quarter 2009 Results 13244 11Sanofi aventis Announces Second Quarter 2009 Results 13244 12Sanofi aventis Announces Second Quarter 2009 Results 13244 13Sanofi aventis Announces Second Quarter 2009 Results 13244 14Sanofi aventis Announces Second Quarter 2009 Results 13244 15Sanofi aventis Announces Second Quarter 2009 Results 13244 16Sanofi aventis Announces Second Quarter 2009 Results 13244 17Sanofi aventis Announces Second Quarter 2009 Results 13244 18Sanofi aventis Announces Second Quarter 2009 Results 13244 19Sanofi aventis Announces Second Quarter 2009 Results 13244 20Sanofi aventis Announces Second Quarter 2009 Results 13244 21Sanofi aventis Announces Second Quarter 2009 Results 13244 22Sanofi aventis Announces Second Quarter 2009 Results 13244 23Sanofi aventis Announces Second Quarter 2009 Results 13244 24Sanofi aventis Announces Second Quarter 2009 Results 13244 25Sanofi aventis Announces Second Quarter 2009 Results 13244 26Sanofi aventis Announces Second Quarter 2009 Results 13244 27GCP Helpdesk 3A Launch Announcement of gcphelpdesk com 53032 1Litepanels to Receive First Ever Emmy Statue for Lighting Equipment Technology 53031 1Litepanels to Receive First Ever Emmy Statue for Lighting Equipment Technology 53031 2
... fair coloring traits contribute to risk, of skin cancer; ... REYKJAVIK, Iceland, May 18 In two papers published,today, ... U.S.,expand upon the company,s recent findings in the genetics ... that certain of these,common variants also confer risk of ...
... and under-studied population ... important insights -, SAN DIEGO, Calif., May 18 ... largest prospective study to evaluate the,response of Latino whites ... therapy with pegylated interferon plus ribavirin. The,results showed PEGASYS(R) ...
Other Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 2PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 3PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 4PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 5PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 6PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 7PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 8
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...
... By combining intra-operative ultrasound ... Medtronic Surgical Navigation Technologies ... product called SonoNav Intra-operative ... built on the high ...
... Bioglue Surgical Adhesive (Bioglue) is a ... bovine serum albumin (BSA) and glutaraldehyde. ... exclusively from bovine spongiform encephalopathy (BSE) ... reduces or inactivates viruses. The solutions ...
... Cebus is Plasmaseal's low cost, low volume ... and the plasma is separated from whole blood ... plasma is transferred to the Cebus single use ... for 30 seconds to activate the concentrating process. ...
Medicine Products: